Literature DB >> 29778400

Stromal heterogeneity in pancreatic cancer and chronic pancreatitis.

Lena Haeberle1, Katja Steiger2, Anna Melissa Schlitter2, Sami Alexander Safi3, Wolfram Trudo Knoefel3, Mert Erkan4, Irene Esposito5.   

Abstract

BACKGROUND/
OBJECTIVES: An abundant stromal reaction is a hallmark of pancreatic ductal adenocarcinoma (PDAC) and chronic pancreatitis (CP). The cells mainly responsible for the stromal reaction are activated pancreatic stellate cells (PSCs). Despite their crucial role, PSCs are not well characterized. PSCs share characteristics with the better-known hepatic stellate cells (HSCs). The aim of this study was a detailed analysis of PSCs in PDAC and CP.
METHODS: Whole-slide specimens of CP (n = 12) and PDAC (n = 10) were studied by histochemistry and immunohistochemistry. The stroma was evaluated using Movat's pentachrome stain. PSCs were tested by immunohistochemistry for PSC markers (α-SMA, CD34, desmin, NGFR, SPARC and tenascin C) and HSC markers (α-crystallin B, CD56, NGF, NT-3, synaptophysin and TrkC). Alpha-SMA, tenascin C, SPARC and NT-3 staining were verified on tissue micro arrays (TMAs) from a well-characterized cohort of 223 PDAC patients. PSCs isolated from human PDAC and CP tissue samples as well as HSCs were evaluated by immunofluorescence.
RESULTS: While the stroma of CP cases was characterized by a collagen-rich fibrosis, PDAC stroma displayed higher mucin content (p = 0.0002). PSCs showed variable expression of tested markers. In PDAC samples, staining of most markers was found around tumor complexes, while CP samples showed a greater variety of localizations. Alpha-SMA staining correlated with collagen-rich fibrosis (p = 0.012), while NT-3 staining correlated with mucin-rich stroma (p = 0.008). A peritumoral staining was confirmed for α-SMA, tenascin C, SPARC and NT-3 in the PDAC TMA cohort (n = 223). In a subgroup of patients with pancreatic head tumors and UICC 2009 IIB (n = 144), α-SMA staining intensity was a prognostic factor for overall survival at uni- and multivariate analysis (p = 0.036 and p = 0.002).
CONCLUSIONS: The close similarities between PSCs and HSCs were confirmed. Heterogeneous expression patterns of the tested markers might reflect different levels of activation or differentiation, or even multiple subpopulations of PSCs. Survival analysis suggests an impact of stromal composition on survival.
Copyright © 2018 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic pancreatitis; Pancreatic cancer; Pancreatic stellate cells; Stromal reaction; Tumor microenvironment

Year:  2018        PMID: 29778400     DOI: 10.1016/j.pan.2018.05.004

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  19 in total

1.  Activity of acute pancreatitis is modified by secreted protein acidic and rich in cysteine ablation.

Authors:  Christoph Ammer-Herrmenau; Laurin Wolf; Syeda S Nasrin; Iswarya Ramu; Roberta Roggiolani; Robert G Goetze; Soeren M Buchholz; Mathias Sendler; Volker Ellenrieder; Albrecht Neesse
Journal:  United European Gastroenterol J       Date:  2022-06-14       Impact factor: 6.866

2.  Spatial and phenotypic characterization of pancreatic cancer-associated fibroblasts after neoadjuvant treatment.

Authors:  Michael Friberg Bruun Nielsen; Michael Bau Mortensen; Mia Dahl Sørensen; Martin Wirenfeldt; Bjarne Winther Kristensen; Henrik Daa Schrøder; Per Pfeiffer; Sönke Detlefsen
Journal:  Histol Histopathol       Date:  2020-01-21       Impact factor: 2.303

3.  Sample preparation strategies for high-throughput mass spectrometry imaging of primary tumor organoids.

Authors:  Jillian Johnson; Joe T Sharick; Melissa C Skala; Lingjun Li
Journal:  J Mass Spectrom       Date:  2020-01-21       Impact factor: 1.982

4.  G2M checkpoint pathway alone is associated with drug response and survival among cell proliferation-related pathways in pancreatic cancer.

Authors:  Masanori Oshi; Ankit Patel; Lan Le; Yoshihisa Tokumaru; Li Yan; Ryusei Matsuyama; Itaru Endo; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

5.  Stroma composition and proliferative activity are related to therapy response in neoadjuvant treated pancreatic ductal adenocarcinoma.

Authors:  Lena Haeberle; Andrea Cacciato Insilla; Anne-Christine Kapp; Katja Steiger; Anna Melissa Schlitter; Björn Konukiewitz; Ihsan Ekin Demir; Helmut Friess; Irene Esposito
Journal:  Histol Histopathol       Date:  2021-03-26       Impact factor: 2.303

6.  Communicator-Driven Data Preprocessing Improves Deep Transfer Learning of Histopathological Prediction of Pancreatic Ductal Adenocarcinoma.

Authors:  Raphael M Kronberg; Lena Haeberle; Melanie Pfaus; Haifeng C Xu; Karina S Krings; Martin Schlensog; Tilman Rau; Aleksandra A Pandyra; Karl S Lang; Irene Esposito; Philipp A Lang
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.575

7.  Typing of pancreatic cancer-associated fibroblasts identifies different subpopulations.

Authors:  Michael Friberg Bruun Nielsen; Michael Bau Mortensen; Sönke Detlefsen
Journal:  World J Gastroenterol       Date:  2018-11-07       Impact factor: 5.742

8.  Visualization and quantification of pancreatic tumor stroma in fresh tissue via ultraviolet surface excitation.

Authors:  Phuong Vincent; Petr Bruza; Scott M Palisoul; Jason R Gunn; Kimberley S Samkoe; P Jack Hoopes; Tayyaba Hasan; Brian W Pogue
Journal:  J Biomed Opt       Date:  2021-01       Impact factor: 3.170

9.  Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer.

Authors:  Tanzeel Khan; Alan M Seddon; Angus G Dalgleish; Said Khelwatty; Nikolaos Ioannou; Satvinder Mudan; Helmout Modjtahedi
Journal:  Oncol Rep       Date:  2020-10-22       Impact factor: 3.906

Review 10.  Pancreatic Fibroblast Heterogeneity: From Development to Cancer.

Authors:  Paloma E Garcia; Michael K Scales; Benjamin L Allen; Marina Pasca di Magliano
Journal:  Cells       Date:  2020-11-12       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.